4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0000950170-25-043973
Chief Financial Officer sold 2,197 shares at $41.23 ($90,582)
- Chief Financial Officer acquired 6,250 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Prasad Raju Chief Financial Officer | 2025-03-20 | Option exercise | +6,250 | 18,964 | D | ||
| Prasad Raju Chief Financial Officer | 2025-03-21 | Sale | −2,197 | $41.23 | $90,582 | 16,767 | D |
| Derivatives | |||||||
| Prasad Raju Chief Financial Officer | 2025-03-20 | Option exercise · Restricted Stock Units | −6,250 | 18,750 | D | ||
| Open-market sales · 2,197 sh · avg $41.23 · $90,582 | |||||||
Loading xslF345X05/ownership.xml…